AbVacc is a company headquartered in the United States.
AbVacc is a biotechnology company focused on discovering and developing novel vaccines and antibody therapeutics for emerging infectious diseases, including viral and antibiotic-resistant bacterial targets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.